{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T06:21:46Z","timestamp":1773037306119,"version":"3.50.1"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>SARS-CoV-2 infection is known to induce systemic biochemical and hematological alterations, particularly in hospitalized patients. However, data regarding subclinical changes in ambulatory, non-hospitalized individuals\u2014especially in Latin American populations\u2014remain limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To compare biochemical and hematological parameters between ambulatory adults with and without serological evidence of prior SARS-CoV-2 infection, in order to identify potential subclinical alterations associated with previous virus exposure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A cross-sectional study was conducted in 201 ambulatory adults from central-northern Mexico between August and December 2020. Anti\u2013SARS-CoV-2 IgG and IgM antibodies were detected using two independent lateral flow immunochromatographic assays. Participants were classified as seropositive only when both assays showed concordant reactivity. Biochemical and hematological parameters were compared between seropositive and seronegative individuals using appropriate parametric or non-parametric tests.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Overall seroprevalence of anti\u2013SARS-CoV-2 antibodies was 22.3%. No significant differences were observed in hematological parameters between seropositive and seronegative participants. In contrast, seropositive individuals exhibited significantly lower high-density lipoprotein cholesterol (HDL-C) levels compared to seronegatives (median: 40.5 vs. 45.3\u202fmg\/dL;\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.009), with significance maintained in females. Liver enzymes were significantly higher among seropositive subjects, including aspartate aminotransferase (AST) (median: 30 vs. 24\u202fU\/L;\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.007) and alanine aminotransferase (ALT) (median: 32.5 vs. 20\u202fU\/L;\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.001). These differences were more pronounced in males. No significant differences were found in glucose, total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), triglycerides (TG), alkaline phosphatase (ALP), or total bilirubin (TB).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Even mild or asymptomatic SARS-CoV-2 infection is associated with subtle but consistent alterations in lipid metabolism and liver enzymes in ambulatory, unvaccinated individuals. These findings support the need for biochemical monitoring after SARS-CoV-2 infection, particularly in populations with high baseline cardiometabolic risk.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1778397","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T05:32:02Z","timestamp":1773034322000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Assessment of biochemical and hematological profiles in outpatients with serological evidence of SARS-CoV-2 infection"],"prefix":"10.3389","volume":"13","author":[{"given":"Samuel","family":"Salazar-Garc\u00eda","sequence":"first","affiliation":[{"name":"Laboratorio de An\u00e1lisis Cl\u00ednicos, Facultad de Ciencias Qu\u00edmicas, Universidad Aut\u00f3noma de San Luis Potos\u00ed","place":["San Luis Potos\u00ed, Mexico"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eunice","family":"Lares-Villase\u00f1or","sequence":"additional","affiliation":[{"name":"Laboratorio de An\u00e1lisis Cl\u00ednicos, Facultad de Ciencias Qu\u00edmicas, Universidad Aut\u00f3noma de San Luis Potos\u00ed","place":["San Luis Potos\u00ed, Mexico"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Manuel","family":"Vargas-Morales","sequence":"additional","affiliation":[{"name":"Laboratorio de An\u00e1lisis Cl\u00ednicos, Facultad de Ciencias Qu\u00edmicas, Universidad Aut\u00f3noma de San Luis Potos\u00ed","place":["San Luis Potos\u00ed, Mexico"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,9]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"108336","DOI":"10.1016\/J.JDIACOMP.2022.108336","article-title":"Post-COVID syndrome, inflammation, and diabetes","volume":"36","author":"Rizvi","year":"2022","journal-title":"J Diabetes Complicat"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/J.CMET.2021.01.016","article-title":"Diabetes, obesity, metabolism, and SARS-CoV-2 infection: the end of the beginning","volume":"33","author":"Drucker","year":"2021","journal-title":"Cell Metab"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1038\/s41591-020-0968-3","article-title":"Extrapulmonary manifestations of COVID-19","volume":"26","author":"Gupta","year":"2020","journal-title":"Nat Med"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"100618","DOI":"10.1016\/j.cpcardiol.2020.100618","article-title":"COVID-19 and multi-organ response","volume":"45","author":"Zaim","year":"2020","journal-title":"Curr Probl Cardiol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"46","DOI":"10.18502\/ijaai.v20i1.5412","article-title":"Interpretation of hematological, biochemical, and immunological findings of COVID-19 disease: biomarkers associated with severity and mortality","volume":"20","author":"Ghazanfari","year":"2021","journal-title":"Iran J Allergy Asthma Immunol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2139\/ssrn.3544826","article-title":"Low serum cholesterol level among patients with COVID-19 infection in Wenzhou, China","author":"Hu","year":"2020","journal-title":"SSRN"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"e0239573","DOI":"10.1371\/journal.pone.0239573","article-title":"Lipoprotein concentrations over time in the intensive care unit COVID-19 patients: results from the ApoCOVID study","volume":"15","author":"Tanaka","year":"2020","journal-title":"PLoS One"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.jacl.2020.04.008","article-title":"Hypolipidemia is associated with the severity of COVID-19","volume":"14","author":"Wei","year":"2020","journal-title":"J Clin Lipidol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.3390\/cells10081869","article-title":"HDL in atherosclerotic cardiovascular disease: in search of a role","volume":"10","author":"Casula","year":"2021","journal-title":"Cells"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1270404","DOI":"10.3389\/fpubh.2023.1270404","article-title":"Exploring disparities and novel insights into metabolic and cardiovascular comorbidities among COVID-19 patients in Mexico","volume":"11","author":"L\u00f3pez-Cuevas","year":"2023","journal-title":"Front Public Health"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/S2213-8587(22)00355-2","article-title":"Risks and burdens of incident dyslipidaemia in long COVID: a cohort study","volume":"11","author":"Xu","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1085988","DOI":"10.3389\/fmed.2023.1085988","article-title":"Biomarkers in long COVID-19: a systematic review","volume":"10","author":"Lai","year":"2023","journal-title":"Front Med"},{"key":"ref13","volume-title":"Endotext","author":"Feingold","year":"2019"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"7217","DOI":"10.1038\/s41598-021-86747-5","article-title":"Low HDL and high triglycerides predict COVID-19 severity","volume":"11","author":"Masana","year":"2021","journal-title":"Sci Rep"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"9843","DOI":"10.1096\/fj.202001451","article-title":"COVID-19-associated dyslipidemia: implications for mechanism of impaired resolution and novel therapeutic approaches","volume":"34","author":"Sorokin","year":"2020","journal-title":"FASEB J"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/s41575-021-00426-4","article-title":"COVID-19 and liver disease: mechanistic and clinical perspectives","volume":"18","author":"Marjot","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"633767","DOI":"10.3389\/fendo.2021.633767","article-title":"Serum uric acid concentrations and risk of adverse outcomes in patients with COVID-19","volume":"12","author":"Chen","year":"2021","journal-title":"Front Endocrinol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"e2022058","DOI":"10.1001\/jamanetworkopen.2020.22058","article-title":"Association of red blood cell distribution width with mortality risk in hospitalized adults with SARS-CoV-2 infection","volume":"3","author":"Foy","year":"2020","journal-title":"JAMA Netw Open"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1515\/cclm-2020-0369","article-title":"Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis","volume":"58","author":"Henry","year":"2020","journal-title":"Clin Chem Lab Med"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"103282","DOI":"10.1016\/j.dsx.2025.103282","article-title":"Prevalence of metabolic syndrome in Latin America: a systematic review and meta-analysis of observational studies","volume":"19","author":"Parra-G\u00f3mez","year":"2025","journal-title":"Diabetes Metab Syndr"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"606","DOI":"10.33552\/OJCRR.2021.05.000606","article-title":"Brazilian lipid cardiovascular risk pre and during the Covid 19 pandemic in asymptomatic and severely affected groups","volume":"5","author":"Carolina Queiroz Cardoso","year":"2021","journal-title":"On J Cardio Res Rep"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"441","DOI":"10.4254\/wjh.v15.i4.441","article-title":"COVID-19 and liver injury: pathophysiology, risk factors, outcome and management in special populations","volume":"15","author":"Roshanshad","year":"2023","journal-title":"World J Hepatol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/S2213-8587(20)30269-2","article-title":"Obesity in Mexico: epidemiology and health policy","volume":"9","author":"Barquera","year":"2020","journal-title":"Curr Obes Rep"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"367","DOI":"10.3748\/wjg.v29.i2.367","article-title":"Non-alcoholic fatty liver disease and COVID-19: harmless companions or disease intensifier?","volume":"29","author":"Dietrich","year":"2023","journal-title":"World J Gastroenterol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"538","DOI":"10.37201\/req\/019.2022","article-title":"Evaluation of two immunochromatographic tests for the detection of antibodies against SARS-CoV-2","volume":"35","author":"Medrano","year":"2022","journal-title":"Rev Esp Quimioter"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41579-022-00846-2","article-title":"Long COVID: major findings, mechanisms and recommendations","volume":"21","author":"Davis","year":"2023","journal-title":"Nat Rev Microbiol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1161\/01.CIR.0000133317.49796.0E","article-title":"Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines","volume":"110","author":"Grundy","year":"2004","journal-title":"Circulation"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1194\/jlr.R300019-JLR200","article-title":"Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host","volume":"45","author":"Khovidhunkit","year":"2004","journal-title":"J Lipid Res"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.cell.2022.01.014","article-title":"Multiple early factors anticipate post-acute COVID-19 sequelae","volume":"185","author":"Su","year":"2022","journal-title":"Cell"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"113486","DOI":"10.1016\/j.jim.2023.113486","article-title":"Multiple early factors anticipate post-acute COVID-19 sequelae","volume":"518","author":"Gaeta","year":"2023","journal-title":"J Immunol Methods"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1778397\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T05:32:03Z","timestamp":1773034323000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1778397\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,9]]},"references-count":30,"alternative-id":["10.3389\/fmed.2026.1778397"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1778397","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,9]]},"article-number":"1778397"}}